{"id":156199,"date":"2025-09-14T12:53:09","date_gmt":"2025-09-14T12:53:09","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/156199\/"},"modified":"2025-09-14T12:53:09","modified_gmt":"2025-09-14T12:53:09","slug":"fangzhou-unveils-xingshi-llm-to-advance-ai-driven-chronic","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/156199\/","title":{"rendered":"Fangzhou Unveils \u201cXingShi\u201d LLM to Advance AI-Driven Chronic"},"content":{"rendered":"

SHANGHAI, Sept. 14, 2025 (GLOBE NEWSWIRE) — At its 10th H2H Healthcare Ecosystem Conference, Fangzhou Inc. (\u201cFangzhou\u201d or the \u201cCompany\u201d) (06086.HK),\u00a0a leader in AI-driven Internet healthcare solutions, announced the release of its proprietary \u201cXingShi\u201d Large Language Model (\u201cXS LLM\u201d), an AI system engineered to address critical inefficiencies in chronic disease management by improving service efficiency, delivering improved personalization, and helping to make better use of physicians\u2019 available time.<\/p>\n

XS LLM integrates multimodal capabilities \u2014 image and speech recognition, natural language processing, large-scale medical knowledge storage, and reasoning \u2014 while achieving advanced performance benchmarks in medical AI. This core system supports five domain-specific intelligent agents: \u201cAI Knowledge Agent\u201d, \u201cAI Guidance Agent\u201d, \u201cAI Pre-Consult Agent\u201d, \u201cAI Doctor Assistant\u201d, and \u201cAI-Electronic Medical Record (EMR) Agent\u201d. Together, these agents create a closed-loop service architecture spanning the full lifecycle of chronic disease management.<\/p>\n

Built as the \u201ccore digital brain\u201d of Fangzhou\u2019s platform, the model currently powers five AI-enabled applications: AI Medication Finder, AI Health Manager, AI Doctor Assistant, AI Academic Assistant, and AI-Powered Search. Each product addresses distinct clinical and patient-side use cases, enabling real-time, precision interventions across medication guidance, patient education, diagnostic assistance, and medical reference.<\/p>\n

Dr. Xie Fangmin, founder, chairman, and CEO of Fangzhou, remarked: \u201cThis launch is not simply a product milestone, but a strategic inflection point. XS LLM provides the technical foundation to embed AI across all layers of chronic disease management, enabling precision, scale and accessibility in healthcare delivery.\u201d<\/p>\n

This launch reflects Fangzhou\u2019s steady AI build-out: from the introduction of its H2H (Hospital-to-Home) digital ecosystem, to the deployment of AI-powered customer service and knowledge base systems, and now to an enterprise-grade medical LLM. With China\u2019s \u201cAI+\u201d policy framework accelerating industrial adoption, Fangzhou indicated that XS LLM will anchor future R&D in chronic disease management applications, reinforcing its mission of delivering scalable, precision healthcare.<\/p>\n

About Fangzhou Inc.
Fangzhou Inc. (06086.HK) is China\u2019s leading online chronic disease management platform, serving 52.8 million registered users and 229,000 physicians (as of June 30, 2025). The Company specializes in delivering tailored medical care and AI-enabled precision medicine solutions. For more information, visit https:\/\/investors.jianke.com<\/a>.<\/p>\n

Media Contact
For further inquiries or interviews, please reach out to:
Xingwei Zhao\u00a0Associate Director of Public Relations Email: pr@jianke.com<\/p>\n

Disclaimer: This press release contains forward-looking statements. Actual results may differ materially from those anticipated due to various factors. Readers are cautioned not to place undue reliance on these statements<\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"SHANGHAI, Sept. 14, 2025 (GLOBE NEWSWIRE) — At its 10th H2H Healthcare Ecosystem Conference, Fangzhou Inc. (\u201cFangzhou\u201d or…\n","protected":false},"author":2,"featured_media":156200,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[45],"tags":[95432,182,95433,181,507,82003,95431,95434,74],"class_list":["post-156199","post","type-post","status-publish","format-standard","has-post-thumbnail","category-artificial-intelligence","tag-xingshi-large-language-model","tag-ai","tag-ai-driven","tag-artificial-intelligence","tag-artificialintelligence","tag-fangzhou-inc","tag-hong-kong-stock-exchange6086","tag-internet-healthcare","tag-technology"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/156199","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=156199"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/156199\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/156200"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=156199"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=156199"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=156199"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}